Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of open label pulse cyclophosphamide therapy on MRI measures of disease activity in five patients with refractory relapsing-remitting multiple sclerosis.
Neurofilaments as biomarkers in multiple sclerosis.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
JCV test stratifies PML risk in antibody-positive MS
Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Biogen Idec and Elan submit applications for first-line use of Tysabri in anti-JCV antibody negative patients with MS
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Animal assisted interventions in neurorehabilitation: A review of the most recent literature.
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
The analysis of correlation between IL-1B gene expression and genotyping in multiple sclerosis patients.
Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study.
Transient gadolinium leakage in natalizumab-treated multiple sclerosis.
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Treatment of HIV and Risk of Multiple Sclerosis.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
Id1 Expression Promotes T Regulatory Cell Differentiation by Facilitating TCR Costimulation.
Merck KGaA Reaches Mutual Agreement with Ono Pharmaceutical to Terminate the License Agreement on Ceralifimod (ONO-4641)
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
Ibuprofen-induced unilateral optic neuritis.

Pages